In vitro transforming potential, intracellular signaling properties and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu and Arg886Trp

    1. Paula Soares1,3
    1. 1Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) – Cancer Biology, Porto, Portugal
    2. 2Molecular Pathology Service, Portuguese Institute of Oncology of Coimbra FG, Coimbra, Portugal
    3. 3Department of Pathology, Medical Faculty, University of Porto, Porto, Portugal
    4. 4Endocrinology Service, Portuguese Institute of Oncology of Coimbra FG, Coimbra, Portugal
    1. Correspondence should be addressed to P Soares; Email: psoares{at}ipatimup.pt

    The authors and journal apologise for an omission in the above paper, which appeared in volume 18 part 4, pages 401–412. The text ‘This work was also supported …

    | Table of Contents